Compagnie Lombard Odier SCmA’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $195K | Buy |
2,720
+1,856
| +215% | +$143K | ﹤0.01% | 254 |
|
|
2025
Q4 | $68.6K | Buy |
+864
| New | +$68.1K | ﹤0.01% | 318 |
|
|
2023
Q1 | – | Sell |
-1,733
| Closed | -$145K | – | 632 |
|
|
2022
Q4 | $161K | Sell |
1,733
-4,567
| -72% | -$441K | ﹤0.01% | 320 |
|
|
2022
Q3 | $601K | Hold |
6,300
| – | – | 0.02% | 198 |
|
|
2022
Q2 | $584K | Buy |
+6,300
| New | +$615K | 0.01% | 188 |
|
|
2022
Q1 | – | Sell |
-4,202
| Closed | -$441K | – | 618 |
|
|
2021
Q4 | $433K | Sell |
4,202
-1,230
| -23% | -$114K | 0.01% | 258 |
|
|
2021
Q3 | $461K | Hold |
5,432
| – | – | 0.01% | 244 |
|
|
2021
Q2 | $454K | Sell |
5,432
-8,993
| -62% | -$736K | 0.01% | 238 |
|
|
2021
Q1 | $1.08M | Hold |
14,425
| – | – | 0.02% | 195 |
|
|
2020
Q4 | $984K | Buy |
14,425
+2,435
| +20% | +$158K | 0.03% | 166 |
|
|
2020
Q3 | $699K | Buy |
11,990
+5,473
| +84% | +$341K | 0.02% | 172 |
|
|
2020
Q2 | $423K | Hold |
6,517
| – | – | 0.01% | 204 |
|
|
2020
Q1 | $385K | Hold |
6,517
| – | – | 0.02% | 193 |
|
|
2019
Q4 | $484K | Sell |
6,517
-6,000
| -48% | -$421K | 0.02% | 190 |
|
|
2019
Q3 | $788K | Buy |
12,517
+6,000
| +92% | +$356K | 0.03% | 152 |
|
|
2019
Q2 | $355K | Sell |
6,517
-503
| -7% | -$27.1K | 0.01% | 206 |
|
|
2019
Q1 | $379K | Sell |
7,020
-1,100
| -14% | -$67.9K | 0.02% | 222 |
|
|
2018
Q4 | $534K | Sell |
8,120
-863
| -10% | -$64.4K | 0.02% | 193 |
|
|
2018
Q3 | $709K | Hold |
8,983
| – | – | 0.02% | 174 |
|
|
2018
Q2 | $578K | Sell |
8,983
-1,619
| -15% | -$107K | 0.02% | 195 |
|
|
2018
Q1 | $659K | Sell |
10,602
-9,270
| -47% | -$665K | 0.02% | 197 |
|
|
2017
Q4 | $1.44M | Buy |
19,872
+11,157
| +128% | +$811K | 0.03% | 202 |
|
|
2017
Q3 | $708K | Hold |
8,715
| – | – | 0.03% | 230 |
|
|
2017
Q2 | $700K | Sell |
8,715
-1,352
| -13% | -$107K | 0.02% | 238 |
|
|
2017
Q1 | $791K | Sell |
10,067
-359
| -3% | -$28.7K | 0.03% | 237 |
|
|
2016
Q4 | $823K | Sell |
10,426
-335
| -3% | -$27.1K | 0.02% | 277 |
|
|
2016
Q3 | $958K | Buy |
10,761
+2,517
| +31% | +$238K | 0.03% | 276 |
|
|
2016
Q2 | $792K | Sell |
8,244
-3,410
| -29% | -$340K | 0.02% | 290 |
|
|
2016
Q1 | $1.21M | Sell |
11,654
-618
| -5% | -$60.1K | 0.04% | 227 |
|
|
2015
Q4 | $1.2M | Sell |
12,272
-86,047
| -88% | -$8.43M | 0.04% | 207 |
|
|
2015
Q3 | $9.48M | Sell |
98,319
-14,303
| -13% | -$1.5M | 0.39% | 48 |
|
|
2015
Q2 | $11.8M | Sell |
112,622
-7,718
| -6% | -$789K | 0.44% | 53 |
|
|
2015
Q1 | $12.4M | Buy |
120,340
+71,159
| +145% | +$7.2M | 0.47% | 48 |
|
|
2014
Q4 | $4.74M | Sell |
49,181
-2,357
| -5% | -$208K | 0.22% | 70 |
|
|
2014
Q3 | $4.1M | Buy |
51,538
+5,963
| +13% | +$470K | 0.17% | 82 |
|
|
2014
Q2 | $3.44M | Buy |
45,575
+12,995
| +40% | +$982K | 0.14% | 93 |
|
|
2014
Q1 | $2.44M | Buy |
32,580
+6,422
| +25% | +$454K | 0.1% | 123 |
|
|
2013
Q4 | $1.87M | Buy |
+26,158
| New | +$1.68M | 0.08% | 139 |
|
Other funds holding CVS
VCM
VPM
Compagnie Lombard Odier SCmA's CVS Position: Q1 2026 in Review
Compagnie Lombard Odier SCmA increased its CVS Health (CVS) stake by 215% in Q1 2026, buying an estimated $143K and bringing the position to 2,720 shares worth $195K. The position accounts for ﹤0.01% of the portfolio, ranked #254.
Compagnie Lombard Odier SCmA first reported a position in CVS in Q4 2013 and has held it in 38 quarters since. The position peaked at $12.4M in Q1 2015. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Compagnie Lombard Odier SCmA held 2,720 shares of CVS Health worth $195K as of Q1 2026.
- Compagnie Lombard Odier SCmA bought 1,856 CVS Health shares in Q1 2026, an estimated $143K.
- CVS Health made up ﹤0.01% of Compagnie Lombard Odier SCmA's portfolio in Q1 2026, its #254 holding.
- Compagnie Lombard Odier SCmA first reported a position in CVS Health in Q4 2013 and has held it in 38 quarters since.
- Compagnie Lombard Odier SCmA's CVS Health position peaked at $12.4M in Q1 2015.
- 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Compagnie Lombard Odier SCmA's 13F filing for Q1 2026, filed 15 Apr 2026.